iBio, Inc. is an innovative biotechnology company headquartered in New York, focused on revolutionizing the production of biopharmaceuticals through plant-based technologies. The firm specializes in contract development and manufacturing services for biologics, including vaccines and therapeutics, catering to both domestic and international clients. Leveraging its proprietary technological advancements, iBio enhances the scalability and efficiency of biologics production, meeting the growing demand for sustainable solutions in the life sciences sector. Through its commitment to innovation and strategic collaborations, iBio is strategically positioned to make significant contributions to the future of healthcare. Show more
Location: 11750 SORRENTO VALLEY ROAD, SAN DIEGO, CA, UNITED STATES, 92121, San Diego, CA, 92121, USA | Website: https://ibioinc.com | Industry: BIOTECHNOLOGY | Sector: HEALTHCARE
Market Cap
69.96M
52 Wk Range
$0.56 - $6.89
Previous Close
$2.15
Open
$2.20
Volume
2,118,875
Day Range
$2.20 - $2.50
Enterprise Value
25.63M
Cash
28.11M
Avg Qtr Burn
-5.665M
Insider Ownership
3.35%
Institutional Own.
71.48%
Qtr Updated
09/30/25
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
| Drug & Indication | Stage & Event | Catalyst Date |
|---|---|---|
IBIO-610 Details Obesity | Phase 1 Initiation | |
IBIO-200/202 Details COVID-19 | Failed Discontinued |
